Nintedanib 150 mg: Evidence and Distribution Integrity in IPF

The medication Nintedanib 150 mg functions as a tyrosine kinase inhibitor which doctors use to treat Idiopathic Pulmonary Fibrosis, an interstitial lung disease that leads to permanent lung tissue dam...